Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pfizer Inc PFE

Alternate Symbol(s):  N.PFE

Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its Oncology products include Ibrance, Xtandi, Inlyta, Bosulif, Lorbrena, Braftovi, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio and Tivdak. Its primary care products include Eliquis, Nurtec ODT/Vydura, Comirnaty, the Prevnar family, Abrysvo, FSME/IMMUN-TicoVac, Paxlovid and Lucira by Pfizer. Its specialty care products include Xeljanz, Enbrel (outside the U.S. and Canada), Inflectra, Cibinqo, Litfulo, Vyndaqel family, Genotropin, Sulperazon, Zavicefta, Medrol and Panzyga.


NYSE:PFE - Post by User

Comment by satchmo6on Jan 15, 2021 11:54pm
88 Views
Post# 32312493

RE:PFE never moves up

RE:PFE never moves up
 
A Portuguese health worker has died two days after getting the Pfizer coronavirus vaccine.. Sonia Acevedo, 41, suffered a 'sudden death' at home on New Year's Day 48 hours after receiving the jab.
 
Hundreds of people in Israel contract Covid-19 days after receiving their first vaccination dose.
 
With the vaccine not providing immediate immunity to the coronavirus, over two hundred Israeli citizens have been diagnosed with the disease days after getting the Pfizer/BioNTech jabs, local media reported.
 
The number of those who got Covid-19 despite being vaccinated was at around 240 people, according to data from Channel 13 News.
 
The Pfizer/BioNTech vaccine, which the Israeli health authorities rely on, doesn’t contain the coronavirus and can’t infect the recipient. But time is needed for the genetic code in the drug to train the immune system to recognize and attack the disease.
 
The course of the US-made vaccine requires two shots. According to the studies, immunity to Covid-19 increases only eight to ten days after the first injection and eventually reaches 50 percent.
 
The second jab is administered 21 days from the first one, while the declared immunity of 95 percent is achieved only a week after that. And, of course, there’s still a five percent chance of getting infected even if the vaccine is at its full potential.
 
Israeli news outlets which reported the figures urged the public to remain vigilant and thoroughly follow all Covid-19 precautions during the month after the first shot of the vaccine is administered.
 
The Jewish state is currently undertaking a massive vaccination campaign, which already saw over one million people or almost 12 percent of the population getting the Pfizer/BioNTech jab. That’s the largest span per capita in the world, according to Oxford University.
 
A Portuguese health worker has died two days after getting the Pfizer coronavirus vaccine.. Sonia Acevedo, 41, suffered a 'sudden death' at home on New Year's Day 48 hours after receiving the jab.

Hundreds of people in Israel contract Covid-19 days after receiving their first vaccination dose.

With the vaccine not providing immediate immunity to the coronavirus, over two hundred Israeli citizens have been diagnosed with the disease days after getting the Pfizer/BioNTech jabs, local media reported.

The number of those who got Covid-19 despite being vaccinated was at around 240 people, according to data from Channel 13 News.

The Pfizer/BioNTech vaccine, which the Israeli health authorities rely on, doesn’t contain the coronavirus and can’t infect the recipient. But time is needed for the genetic code in the drug to train the immune system to recognize and attack the disease.

The course of the US-made vaccine requires two shots. According to the studies, immunity to Covid-19 increases only eight to ten days after the first injection and eventually reaches 50 percent.

The second jab is administered 21 days from the first one, while the declared immunity of 95 percent is achieved only a week after that. And, of course, there’s still a five percent chance of getting infected even if the vaccine is at its full potential.

Israeli news outlets which reported the figures urged the public to remain vigilant and thoroughly follow all Covid-19 precautions during the month after the first shot of the vaccine is administered.

The Jewish state is currently undertaking a massive vaccination campaign, which already saw over one million people or almost 12 percent of the population getting the Pfizer/BioNTech jab. That’s the largest span per capita in the world, according to Oxford University.
<< Previous
Bullboard Posts
Next >>